FDC Logo Tan Sheet Logo
 
Health News Daily 
"The Pink Sheet" 
FDAAdvisoryCommittee.com 
The Rose Sheet 
   
HomeSubscribeAdvertisingPast 3 IssuesStaff My AccountHelpContact
Order Reprint
search within:
 


 November 17, 2008 Volume 16 , Number 46 

The JUPITER Results: Will The Planets Align For OTC Statins?
AstraZeneca’s JUPITER trial on Crestor (rosuvastatin) greatly expands the pool of patients who may benefit from statin use, which could help make the case for an OTC switch in the cholesterol-lowering class in the future.   READ MORE>>
Europe Will Clarify Centralized Switch Process As Alli Switch Looms
The European Commission will issue additional guidance on its centralized nonprescription switch process to clarify its authority over member states to designate products’ sale status.   READ MORE>>
Zyrtec OTC Launch Does Not Deliver Knockout To Rx Remedies – Report
Fewer consumers than expected have switched from Rx products to OTC Zyrtec in part because managed care organizations are not discouraging use of prescription allergy medications, according to research by Nielsen and Wolters Kluwer Health.   READ MORE>>
 
 
  •  
  • Perrigo’s Thirst For Expansion Reaches Electrolyte Market With Unico Buy
     
  •  
  • Low-Dose Aspirin Reduces CV Events In Type 2 Diabetes Patients Over Age 65
     
     
  •  
  • Chart: Weekly Trademark Review -- Nov. 11, 2008

     
  •  
  • FDA melamine alert
     
  •  
  • CPSC final rule on packaging law
     
  •  
  • J&J recalls gas relief product
     
  •  
  • Store brand acne cream recalled
     
     
  •  
  • Baucus Starts Early With Heath Care Proposal, Makes Prevention A Priority
     
  •  
  • Democrats’ Gains Galvanize Leahy’s Push For Patent Reform
     
  •  
  • Chart: Election Results For Key Congressional Committees
     
     
  •  
  • Vitamins E And C Trial Shows No CVD-Prevention Benefits In “Healthy” Men
     
  •  
  • “Look Before You Leap” With Supplement Delivery Innovations – Experts
     
     
  •  
  • NBTY Forced To Hike Prices By Leiner Integration Costs, Shrinking Margins
     
  •  
  • Sales & Earnings In Brief

    HomeSubscribeAdvertisingPast 3 IssuesStaff My AccountHelpContact

      FDC Reports is the publisher of "The Pink Sheet"; "The Pink Sheet" DAILY; "The Gray Sheet"; FDAAdvisoryCommittee.com; "The Tan Sheet"; "The Rose Sheet"; Pharmaceutical Approvals Monthly; "The Gold Sheet"; "The Silver Sheet"; Health News Daily; PharmAsia News, an Elsevier company.